{"nct_id":"NCT03217812","title":"A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)","status":"COMPLETED","status_verified_date":"2024-04","start_date":"2017-11-23","start_date_type":"ACTUAL","primary_completion_date":"2020-07-02","primary_completion_date_type":"ACTUAL","completion_date":"2024-03-08","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["JNJ"]}